http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112020024842-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9880469dc8f12dad7c3ad95c6ab31fe
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60
filingDate 2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_404adc87a9c52611632f0be6733d521a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_745bf2e77dc5c9f65b59c020978ce266
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_305642e4aa3da4145a52ec77bbfaf191
publicationDate 2021-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112020024842-A2
titleOfInvention dosage and effect of c5a antagonist with hip-associated vasculitis
abstract the invention relates to methods for treating hip associated vasculitis in a human in need thereof, the method comprising administering to the human a therapeutically effective amount of avacopan, or a pharmaceutically acceptable salt thereof, so that the level of factor of complement in plasma bb, c3a or c5a does not change significantly in humans during treatment.
priorityDate 2018-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421378319
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448766806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587381
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID556399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567890
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3875734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6394114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31307
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457169682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49841217
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426100811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411277171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452549961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573201
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5RBP8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426391582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135409387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509178

Total number of triples: 82.